Clinical Trial Update: Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating primary tumor resection with sintilimab and chemotherapy in advanced non-small cell lung cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Jianxing He | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING